Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 2 Postoperative Nausea and Vomiting 1 Pain, Postoperative 1 Neoplasms 1 Nausea 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Agnosia 1

Interventions

Dexamethasone 12 Palonosetron 11 Aprepitant 11 Ondansetron 8 Olanzapine 5 Calcium Dobesilate 4 netupitant 2 fosaprepitant 2 Tropisetron 2 Radiotherapy 2 Fluorouracil 2 yangzheng xiaoji 1 rolapitant 1 ramosetron 1 niraparib 1 netupitant, palosentron drug combination 1 nabiximols 1 isatuximab 1 ginger extract 1 dolasetron 1 casopitant 1 Yoga 1 Therapeutics 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Paclitaxel 1 Oxaliplatin 1 Octreotide 1 Midazolam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nausea × ramosetron × Clear all

NCT01046461 2012-02-17

RAD

Hallym University Medical Center

Phase 2 Unknown

Nausea, Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡